Dr. Kerry Courneya
๐ค SpeakerAppearances Over Time
Podcast Appearances
So if I had to rank them, you know, that would certainly be above the sedentary behavior.
Part of the challenge in those studies, it's very much harder to measure
You know, all these little things that people do over the course of the day where they're a little bit better at recalling vigorous intensity and moderate intensity exercise.
But nevertheless, those movements are going to be beneficial because we know they are going to expend energy.
So it's going to be similar to these other exercise benefits.
And as I mentioned, you know, we're no longer...
recommending this at least 10 minute duration as the minimum of a exercise break.
So if it's moderate intensity and you're able to accumulate it in a few minutes here and a few minutes there, there could be beneficial effects of that type of exercise.
Yeah, yeah.
No, it's very interesting research.
And there, of course, they're using the objective accelerometer, so they're not relying on the person's recall, and they get a better indication of that.
But yeah, if you're engaged in this type of vigorous intensity exercise, even if it's only for a minute here, a couple minutes there, depending on how much you accumulate during the day, there's going to be beneficial effects to that.
Yeah, in the absence of smoking and obesity, exercise is really important for lowering the risk of cancer.
So there's been a lot of exciting progress in cancer treatment over the last couple of decades.
You know, the mainstays of cancer treatment in the past were surgery, very important, radiation therapy, chemotherapy, and hormone therapies.
And now over the last couple of decades, there's been a lot of research on so-called targeted therapies and immunotherapies.
And these have really changed how these patients are treated.
What it does mean, though, is many of these patients are in for extensive treatments.
I think cancer patients are probably the most heavily treated chronic disease group that we have.
So patients get what we call multimodal treatment.